HPS Pharmacies wish to advise that Sanofi is experiencing a supply interruption for Hyalase® ampoules as follows:
Hyaluronidase 1,500 IU
This short-term supply interruption is due to production issues. Supplies of Hyalase® powder for injection ampoules are expected to return to normal by late December 2019.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Sanofi-Aventis Australia on 1800 818 806 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates